The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
89029158 8902915 8 F 200511 20160726 20121112 20160728 EXP US-009507513-1211USA004403 MERCK 0.00 F Y 0.00000 20160728 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
89029158 8902915 1 PS FOSAMAX ALENDRONATE SODIUM 1 Oral 70 MG, UNK 20560 70 MG TABLET
89029158 8902915 2 SS FOSAMAX ALENDRONATE SODIUM 1 Oral 70 MG, QW 20560 70 MG TABLET /wk
89029158 8902915 3 SS ALENDRONATE SODIUM. ALENDRONATE SODIUM 1 Oral 70 MG, QW 20560 70 MG TABLET /wk
89029158 8902915 4 SS ACTONEL RISEDRONATE SODIUM 1 Oral 150 MG, UNK 0 150 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
89029158 8902915 1 Osteoporosis
89029158 8902915 3 Osteoporosis
89029158 8902915 4 Osteoporosis

Outcome of event

Event ID CASEID OUTC COD
89029158 8902915 DS
89029158 8902915 HO
89029158 8902915 OT
89029158 8902915 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
89029158 8902915 Adverse event
89029158 8902915 Anaemia of chronic disease
89029158 8902915 Anaemia postoperative
89029158 8902915 Arteriosclerosis
89029158 8902915 Atrial fibrillation
89029158 8902915 Blood osmolarity decreased
89029158 8902915 Cardiac failure congestive
89029158 8902915 Cardiopulmonary failure
89029158 8902915 Chronic kidney disease
89029158 8902915 Constipation
89029158 8902915 Decreased appetite
89029158 8902915 Dyspnoea
89029158 8902915 Fall
89029158 8902915 Femur fracture
89029158 8902915 Fungal oesophagitis
89029158 8902915 Gastrooesophageal reflux disease
89029158 8902915 Hip arthroplasty
89029158 8902915 Hypertension
89029158 8902915 Hyponatraemia
89029158 8902915 International normalised ratio increased
89029158 8902915 Intestinal ischaemia
89029158 8902915 Joint arthroplasty
89029158 8902915 Joint effusion
89029158 8902915 Joint swelling
89029158 8902915 Leukocytosis
89029158 8902915 Macular degeneration
89029158 8902915 Neuroma
89029158 8902915 Open reduction of fracture
89029158 8902915 Palpitations
89029158 8902915 Peptic ulcer
89029158 8902915 Peripheral swelling
89029158 8902915 Renal failure
89029158 8902915 Toxicity to various agents
89029158 8902915 Transient ischaemic attack
89029158 8902915 Upper-airway cough syndrome
89029158 8902915 Urinary incontinence
89029158 8902915 Vaginal infection
89029158 8902915 Vision blurred
89029158 8902915 Vitamin D deficiency
89029158 8902915 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
89029158 8902915 1 2001 200809 0
89029158 8902915 2 200306 2008 0
89029158 8902915 3 200805 200808 0
89029158 8902915 4 200809 200812 0